Authors: TALBOT DC BOVEN E DOBBS N VARCOE S RUIJTER R FRASER S

Citation: Dc. Talbot et al., PHASE-I AND PHARMACOKINETIC STUDY OF DX-8951F, A NOVEL TOPOISOMERASE-I INHIBITOR, USING A 30 MINUTE INFUSION WEEKLY X-3 EVERY 4 WEEKS, Annals of oncology, 9, 1998, pp. 247-247

Authors: DEBONO JS PROPPER D ELLARD S STEINER J BEVAN P DOBBS N FLANAGAN E GANESAN TS TALBOT DC CAMPBELL S TWELVES C HARRIS A

Citation: Js. Debono et al., A PHASE-I STUDY OF XR5000 (DACA) BY 120 HOUR INTRAVENOUS-INFUSION, Annals of oncology, 9, 1998, pp. 449-449

Authors: OBYRNE KJ DOBBS N PROPPER DJ BRAYBROOKE JP KOUKOURAKIS MI TALBOT DC SCHALLY AV HARRIS AL

Citation: Kj. Obyrne et al., THE OCTAPEPTIDE SOMATOSTATIN ANALOG RC-160, SUPPRESSES IGF-I AND ELEVATED PROLACTIN LEVELS IN BREAST-CANCER PATIENTS, British Journal of Cancer, 78, 1998, pp. 113-113

Authors: PAZARES L DOBBS N TWELVES C

Citation: L. Pazares et al., DOXORUBICIN-INDUCED CARDIOTOXICITY, The New England journal of medicine, 333(20), 1995, pp. 1360-1360